The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 519.00
Bid: 519.20
Ask: 519.60
Change: 2.00 (0.39%)
Spread: 0.40 (0.077%)
Open: 520.60
High: 524.20
Low: 518.80
Prev. Close: 517.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Dec 2019 11:01

RNS Number : 5302W
B&M European Value Retail S.A.
11 December 2019
 

 

 

 

ANNEXE A: Standard form for notification of major holdings

 

Form to be used for the purposes of notifying a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities (referred to as "the Transparency Law" and "the Transparency Regulation")

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the CSSF)i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

 

B&M EUROPEAN VALUE RETAIL SA

2. Reason for the notification (please tick the appropriate box or boxes):

 

 X An acquisition or disposal of voting rights

 X An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv :

Name : Barclays plc, London UK

City and country of registered office (if applicable):

 

 

4. Full name of shareholder(s) (if different from 3.)v:

 

5. Date on which the threshold was crossed or reachedvi:

18 November 2019

6. Total positions of person(s) subject to the notification obligation:

 

% of voting rights attached to shares (total of 7.A)

% of voting rights through financial instruments(total of 7.B.1 + 7.B.2)

Total of both in % (7.A + 7.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

2.763%

2.442%

5.205%

1000561222

Position of previous notification (if applicable)

%

%

%

 

      

 

 

 

7. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii:

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 8 of the

Transparency Law)

Indirect

(Art 9 of the

Transparency Law)

Direct

(Art 8 of the

Transparency Law)

Indirect

(Art 9 of the Transparency Law)

LU1072616219

27647591

%

2.763%

%

%

%

%

SUBTOTAL A

(Direct & Indirect)

27647591

2.763%

 

 

B 1: Financial Instruments according to Art. 12(1)(a) of the Transparency Law

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

Right to recall (Collateral)

2364772

0.236 %

 

Right to recall (Loan)

19134564

1.912 %

 

%

 

 

 

SUBTOTAL B.1

21499336

2.149 %

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 12(1)(b) of the Transparency Law

 

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Physical or cash settlementxii

Number of voting rights

% of voting rights

 

CFD

NA

NA

Cash

215271

0.022%

 

Equity Swap

12/12/2019 - 03/03/2020

NA

Cash

700000

 

0.070 %

 

Portfolio Swap

23/12/2019 - 04/09/2020

NA

Cash

2020554

0.202 %

 

 

 

 

SUBTOTAL B.2

2935825

0.293%

 

 

 

 

 

 

 

 

 

 

8. Information in relation to the person subject to the notification obligation:

(please tick the applicable box)

 

 Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii

 

X Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please provide a separate organisational chart in case of a complex structure):

 

 

Namexv

% of voting rights held by ultimate controlling person or entity or held directly by any subsidiary if it equals or is higher than the notifiable

threshold

% of voting rights through financial instruments held by ultimate controlling person or entity or held directly by any subsidiary if it equals or is higher than the notifiable

threshold

Total of both

Directly controlled by (use number(s) from 1st column)

 

 

Barclays Plc

%

%

5.205%

 

 

 

Barclays Bank Plc

%

%

%

 

 

 

Barclays Capital Securities Ltd

%

%

%

 

 

 

 

%

%

%

 

 

 

 

%

%

%

 

 

 

 

 

9. In case of proxy voting:

 

 

 

 

 

10. Additional informationxvi:

 

 

                  

 

Done at

London

On

22/11/2019

 

 

 

 

 

 

Notes

 

i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresholds or information regarding capital holdings.

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity).

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in Article 9 (b) to (h) of the Transparency Law; or (c) the holder of financial instruments referred to in Article 12(1) of of the Transparency Law.

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in points (b) to (h) of Article 9 of the Transparency Law, the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 9 of that Law, the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 9 of that Law, the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 9 of that Law, the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 9 of that Law, the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 8, under letters (a) to (d) of Article 9 of that Law or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 9 of that Law, the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 9 of that Law, the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 9 of that Law, the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in Article 9 (b) to (h) of the Transparency Law. This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 9 of that Law unless the percentage of voting rights held by the shareholder is lower than the 5% threshold for the disclosure of voting rights holdings (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the 5% threshold, please note that it is not necessary to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (Article 12(1a) of the Transparency Law).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity also has to be presented in the cases in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only then the market always gets the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.). Numbers shall be attributed to all persons or entities within the group in column 1 in order to allow a clear indication of the control structure in column 6. The names of all undertakings of the control chain shall be provided in column 2, even if the number of the directly held voting rights and/or financial instruments is not equal or higher than the notifiable threshold. Columns 3 & 4 shall indicate the holdings of those persons or entities directly holding the voting rights and/or financial instruments if the holding is equal or higher than the notifiable threshold.

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFFLFSFFUSEIE
Date   Source Headline
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.